Home/Filings/4/0001214659-15-007703
4//SEC Filing

Anthera Pharmaceuticals Inc 4

Accession 0001214659-15-007703

CIK 0001316175operating

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:21 PM ET

Size

5.2 KB

Accession

0001214659-15-007703

Insider Transaction Report

Form 4
Period: 2015-11-11
Hislop Colin
Sr. VP, Cardiovasc. Prod.
Transactions
  • Sale

    Common Stock

    2015-11-11$5.38/sh5,000$26,90019,147 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,897

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001316175

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:21 PM ET
Size
5.2 KB